LU Bio is a holding company partially owned by Lund University with three majority owned development companies within the pharmaceutical field. The ownership is split between Lund University, a consortia of private investors and additional investors. The therapeutic areas that the portfolio companies comprises concerns cancer, sepsis and hair loss. For a more detailed presentation of the projects and companies please see the links.